+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Madecassoside

BP0911
34540-22-2
98%
Phytopurify
Madecassoside is a triterpenoid saponin that is a trisaccharide derivative of madecassic acid. Isolated from Centella asiatica, it exhibits anti-inflammatory, antioxidant and antirheumatic activities. It has a role as an antioxidant, an antirheumatic drug, an anti-inflammatory agent, a vulnerary and a plant metabolite. It is a pentacyclic triterpenoid, a carboxylic ester, a triterpenoid saponin and a trisaccharide derivative. It is functionally related to a madecassic acid. Madecassoside is a mechanism-based inhibitor of CYP2C19 and CYP3A4, which has antioxidant, anti-inflammatory, anti-apoptosis, wound-healing, and neuroprotective activities, It may have cardioprotective effects in LPS-mediated through inhibition of ERK, p38, and NF-κB activity, it inhibited the pro-inflammatory mediators, including COX-2 expression, PGE2 production, TNF-αand IL-6 levels and the up-regulation anti-inflammatory molecule IL-10.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0911-20mg 20mg
BP0911-100mg 100mg
BP0911-1000mg 1000mg
BP091101-1kg 1kg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related diseases

Related targets

MAPK1 ACHE CREB1 BDNF NGF

Product drug property prediction parameters

  • 335.4400

  • 1.5008

  • 1.5007

  • .2517

  • .5429

  • .6173

  • Low

  • 66.1495

  • 6.6263

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • Yes